Immunoparesis defined by heavy+light chain suppression is a novel marker of long‐term outcomes in cardiac AL amyloidosis
Sajitha Sachchithanantham; Oscar Berlanga; Azra Alvi; Shameem A. Mahmood; Helen J. Lachmann; Julian D. Gillmore; Philip N. Hawkins; Stephen Harding; Ashutosh D. Wechalekar
Author Information: Centre for Amyloidosis and Acute Phase Proteins
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.